Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1510123 | 0.94 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL17200847 | 0.94 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL2960 | 0.91 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL24983 | 0.89 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL509984 | 0.89 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL17200836 | 0.89 | MEN1 (0.39) | — | |
| SCHEMBL17200853 | 0.89 | MEN1 (0.39) | — | |
| SCHEMBL2448213 | 0.89 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL2449105 | 0.84 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL9175726 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 444 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117242396-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | 日产化学株式会社 | 2023-12-15 | — | — | CN | claimed |
| WO-2023074568-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2023-05-04 | — | — | WO | claimed |
| CN-110383522-B | Material for light-emitting element, and organometallic complex | 株式会社半导体能源研究所 | 2023-04-25 | — | — | CN | claimed |
| US-11522142-B2 | Light-emitting element material, light-emitting element, light-emitting device, electronic device, lighting device, and organometallic complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2022-12-06 | — | — | US | claimed |
| EP-3294727-B1 | ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER | NOVALED GMBH (DE) | 2021-08-04 | — | — | EP | claimed |
| US-11081652-B2 | Organic light-emitting diode comprising different matrix compounds in the first and second electron transport layer | NOVALED GMBH (DE) | 2021-08-03 | — | — | US | claimed |
| CN-106279196-B | Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device | 株式会社半导体能源研究所 | 2021-06-29 | — | — | CN | claimed |
| CN-107750404-B | Organic light emitting diode comprising different host compounds in first and second electron transport layers | 诺瓦尔德股份有限公司 | 2021-06-04 | — | — | CN | claimed |
| US-20200347011-A1 | DOUBLE-HEADED PROTEASE INHIBITOR | UBE INDUSTRIES, LTD. (JP) | 2020-11-05 | — | — | US | claimed |
| US-20200321541-A1 | LIGHT EMITTING ELEMENT, LIGHT-EMITTING DEVICE, DISPLAY DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-10-08 | — | — | US | claimed |
| US-20020137784-A1 | Potassium channel blocking agents | NEUROSEARCH A/S | 2002-09-26 | — | — | US | claimed |
| US-20020128279-A1 | Potassium channel blocking agents | NEUROSEARCH A/S (DK) | 2002-09-12 | — | — | US | claimed |
| US-6380180-B1 | BENZIMIDAZOLE COMPOUNDS FOR TREATMENT OF ASTHMA, VASOSPASM, MEMORY LOSS, MIGRAINE AND OTHERS DISEASES ASSOCIATED WITH POTASSIUM CHANNELS | NEUROSEARCH A/S (DK) | 2002-04-30 | — | — | US | claimed |
| US-20020049246-A1 | Potassium channel blocking agents | NEUROSEARCH A/S | 2002-04-25 | — | — | US | claimed |
| EP-1196419-A1 | POTASSIUM CHANNEL BLOCKING AGENTS | NEUROSEARCH A/S (DK) | 2002-04-17 | — | — | EP | claimed |
| EP-0906261-B1 | HYDROFORMYLATION PROCESS AND CATALYSTS SUITABLE THEREFOR CONTAINING PHOSPHORUS COMPOUNDS AS LIGANDS | BASF AG (DE) | 2001-05-09 | — | — | EP | claimed |
| EP-1091942-A1 | POTASSIUM CHANNEL BLOCKING AGENTS | NEUROSEARCH A/S (DK) | 2001-04-18 | — | — | EP | claimed |
| US-6194447-B1 | ASTHMA, ANTICONVULSANTS, COGNITION ACTIVATORS, BRAIN DISORDERS, PSYCHOLOGICAL DISORDERS, CARDIOVASCULAR DISORDERS,GASTROINTESTINAL DISORDERS | NEUROSEARCH A/S (DK) | 2001-02-27 | — | — | US | claimed |
| WO-2001002406-A1 | POTASSIUM CHANNEL BLOCKING AGENTS | NEUROSEARCH A/S (DK) | 2001-01-11 | — | — | WO | claimed |
| WO-2000001676-A1 | POTASSIUM CHANNEL BLOCKING AGENTS | NEUROSEARCH A/S (DK) | 2000-01-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128279-A1 | Potassium channel blocking agents | KCND2, KCNJ2, KCNN3 | ALDH1A1 3648/4885 |
| US-20200347011-A1 | DOUBLE-HEADED PROTEASE INHIBITOR | TMPRSS15, SPINT2, PRSS2 | ALDH1A1 1685/4885 |
| US-11081652-B2 | Organic light-emitting diode comprising different matrix compounds in the first and second electron transport layer | CYBA, CLTB, MAP1LC3B | ALDH1A1 122/4885 |
| US-11522142-B2 | Light-emitting element material, light-emitting element, light-emitting device, electronic device, lighting device, and organometallic complex | L1CAM, NR2E3, LAGE3 | ALDH1A1 387/4885 |
| US-20020137784-A1 | Potassium channel blocking agents | KCNH2, KCNH3, KCND2 | ALDH1A1 3057/4885 |
| US-20020049246-A1 | Potassium channel blocking agents | KCNH2, KCNH3, KCND2 | ALDH1A1 3057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.